{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:59:49Z","timestamp":1769821189172,"version":"3.49.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["223388"],"award-info":[{"award-number":["223388"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011272","name":"FP7 Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.expneurol.2020.113286","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T12:32:36Z","timestamp":1584534756000},"page":"113286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Olesoxime improves cerebral mitochondrial dysfunction and enhances A\u03b2 levels in preclinical models of Alzheimer's disease"],"prefix":"10.1016","volume":"329","author":[{"given":"Gunter P.","family":"Eckert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Schamim H.","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janett","family":"Eckmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Hagl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter E.","family":"Muller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Friedland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2020.113286_bb0005","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1089\/jmf.2011.0226","article-title":"Inhibition of acetylcholinesterase activity and Fe2+\u2212induced lipid peroxidation in rat brain in vitro by some citrus fruit juices","volume":"15","author":"Ademosun","year":"2012","journal-title":"J. Med. Food"},{"key":"10.1016\/j.expneurol.2020.113286_bb0010","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S1474-4422(17)30085-6","article-title":"Safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type 3 spinal muscular atrophy: a randomised, double-blind, placebo-controlled phase 2 trial","volume":"16","author":"Bertini","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2020.113286_bb0015","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0014-4886(03)00252-8","article-title":"Time sequence of maturation of dystrophic neurites associated with a beta deposits in APP\/PS1 transgenic mice","volume":"184","author":"Blanchard","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2020.113286_bb0020","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1124\/jpet.107.123000","article-title":"Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis","volume":"322","author":"Bordet","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2020.113286_bb0025","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1124\/jpet.108.139410","article-title":"Specific antinociceptive activity of Cholest-4-en-3-one, Oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy","volume":"326","author":"Bordet","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2020.113286_bb0030","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3390\/ph3020345","article-title":"Olesoxime (TRO19622): a novel mitochondrial-targeted neuroprotective compound","volume":"3","author":"Bordet","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.expneurol.2020.113286_bb0035","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/S0024-3205(99)00442-7","article-title":"Elevated oxidative stress in models of normal brain aging and Alzheimer's disease","volume":"65","author":"Butterfield","year":"1999","journal-title":"Life Sci."},{"key":"10.1016\/j.expneurol.2020.113286_bb0040","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrd2896","article-title":"Alzheimer's disease: strategies for disease modification","volume":"9","author":"Citron","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.expneurol.2020.113286_bb0045","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1093\/brain\/awv290","article-title":"Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat","volume":"138","author":"Clemens","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2020.113286_bb0050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13195-016-0207-9","article-title":"Drug development in Alzheimer's disease: the path to 2025","volume":"8","author":"Cummings","year":"2016","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.expneurol.2020.113286_bb0055","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00702-015-1387-3","article-title":"1H- and 13C-NMR spectroscopy of Thy-1-APPSL mice brain extracts indicates metabolic changes in Alzheimer's disease","volume":"122","author":"Doert","year":"2015","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.expneurol.2020.113286_bb0060","series-title":"Pharmacopsychiatry","first-page":"S22","article-title":"Effects of hyperforin on the fluidity of brain membranes","author":"Eckert","year":"2001"},{"key":"10.1016\/j.expneurol.2020.113286_bb0065","doi-asserted-by":"crossref","DOI":"10.14336\/AD.2017.1014","article-title":"Mitochondrial pharmacology of dimebon (latrepirdine) calls for a new look at its possible therapeutic potential in alzheimer's disease","volume":"9","author":"Eckert","year":"2018","journal-title":"Aging Dis."},{"key":"10.1016\/j.expneurol.2020.113286_bb0070","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.biocel.2012.06.009","article-title":"Mitochondria: mitochondrial membranes in brain ageing and neurodegeneration","volume":"45","author":"Eckmann","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.expneurol.2020.113286_bb0075","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-014-8663-3","article-title":"Mitochondrial membrane fluidity is consistently increased in different models of Huntington disease: restorative effects of Olesoxime","volume":"50","author":"Eckmann","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2020.113286_bb0080","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/B978-0-12-394625-6.00007-6","article-title":"Mitochondrial dysfunction: cause and consequence of Alzheimer's disease","volume":"127","author":"Friedland-Leuner","year":"2014","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.expneurol.2020.113286_bb0085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/alzrt181","article-title":"Dementia in the oldest old: a multi-factorial and growing public health issue","volume":"5","author":"Gardner","year":"2013","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.expneurol.2020.113286_bb0090","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1111\/bph.12094","article-title":"Olesoxime protects embryonic cortical neurons from camptothecin intoxication by a mechanism distinct from BDNF","volume":"168","author":"Gouarn\u00e9","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2020.113286_bb0095","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/bph.12939","article-title":"Protective role of olesoxime against wild-type alpha-synuclein-induced toxicity in human neuronally differentiated SHSY-5Y cells","volume":"172","author":"Gouarne","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2020.113286_bb0100","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2174\/0929867321666141106122628","article-title":"Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease","volume":"22","author":"Guzior","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.expneurol.2020.113286_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1179\/1476830515Y.0000000040","article-title":"Rice bran extract improves mitochondrial dysfunction in brains of aged NMRI mice","volume":"19","author":"Hagl","year":"2016","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.expneurol.2020.113286_bb0110","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.neurobiolaging.2007.12.005","article-title":"Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice","volume":"30","author":"Hauptmann","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2020.113286_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108674","article-title":"Cytoprotective effects of olesoxime on isolated human pancreatic islets in order to attenuate apoptotic pathway","author":"Kaviani","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.expneurol.2020.113286_bb0120","first-page":"1","article-title":"An effective treatment for Alzheimer's disease must consider both amyloid and tau","volume":"7","author":"Lansdall","year":"2014","journal-title":"BioscienceHorizons"},{"key":"10.1016\/j.expneurol.2020.113286_bb0125","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1107\/S1744309109008343","article-title":"Structure of pig heart citrate synthase at 1.78 A resolution","volume":"65","author":"Larson","year":"2009","journal-title":"Acta Crystallogr Sect F Struct Biol Cryst Commun"},{"key":"10.1016\/j.expneurol.2020.113286_bb0130","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/ene.12344","article-title":"A phase II-III trial of olesoxime in subjects with amyotrophic lateral sclerosis","volume":"21","author":"Lenglet","year":"2014","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.expneurol.2020.113286_bb0135","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s12035-012-8307-4","article-title":"From mitochondrial dysfunction to amyloid beta formation: novel insights into the pathogenesis of Alzheimer's disease","volume":"46","author":"Leuner","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2020.113286_bb0140","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3109\/00207454.2013.804523","article-title":"TRO19622 promotes myelin repair in a rat model of demyelination","volume":"123","author":"Li","year":"2013","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.expneurol.2020.113286_bb0145","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/ana.22593","article-title":"Olesoxime accelerates myelination and promotes repair in models of demyelination","volume":"71","author":"Magalon","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2020.113286_bb0150","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10863-014-9592-6","article-title":"Mitochondrial cholesterol: mechanisms of import and effects on mitochondrial function","volume":"48","author":"Martin","year":"2016","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.expneurol.2020.113286_bb0155","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1523\/JNEUROSCI.2225-10.2011","article-title":"The mitochondrial permeability transition pore regulates nitric oxide-mediated apoptosis of neurons induced by target deprivation","volume":"31","author":"Martin","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2020.113286_bb0160","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/jcpt.12112","article-title":"Potential novel targets for Alzheimer pharmacotherapy: II. Update on secretase inhibitors and related approaches","volume":"39","author":"Mikulca","year":"2013","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.expneurol.2020.113286_bb0165","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3233\/JAD-141002","article-title":"Cardiolipin profile changes are associated to the early synaptic mitochondrial dysfunction in Alzheimer's disease","volume":"43","author":"Monteiro-Cardoso","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.expneurol.2020.113286_bb0170","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.bcp.2018.09.026","article-title":"Alzheimer's disease (AD) therapeutics - 1: repeated clinical failures continue to question the amyloid hypothesis of AD and the current understanding of AD causality","volume":"158","author":"Mullane","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.expneurol.2020.113286_bb0175","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12035-010-8141-5","article-title":"Mitochondrial dysfunction: common final pathway in brain aging and Alzheimer's disease--therapeutic aspects","volume":"41","author":"Muller","year":"2010","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2020.113286_bb0180","series-title":"Mitochondrial Function and Biogenetics","first-page":"149","article-title":"Function and dysfunction of the oxidative phospharylation system","author":"Nijtmans","year":"2004"},{"key":"10.1016\/j.expneurol.2020.113286_bb0185","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.etp.2010.06.002","article-title":"Antioxidant and inhibitory effect of red ginger (Zingiber officinale var. Rubra) and white ginger (Zingiber officinale roscoe) on Fe(2+) induced lipid peroxidation in rat brain in vitro","volume":"64","author":"Oboh","year":"2012","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.expneurol.2020.113286_bb0190","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.bbamem.2009.01.012","article-title":"The interaction of beta-amyloid protein with cellular membranes stimulates its own production","volume":"1788","author":"Peters","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.expneurol.2020.113286_bb0195","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11064-015-1765-0","article-title":"MH84: a novel \u03b3-secretase modulator\/PPAR\u03b3 agonist--improves mitochondrial dysfunction in a cellular model of Alzheimer's disease","volume":"41","author":"Pohland","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.expneurol.2020.113286_bb0200","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13195-018-0342-6","article-title":"MH84 improves mitochondrial dysfunction in a mouse model of early Alzheimer's disease","volume":"10","author":"Pohland","year":"2018","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.expneurol.2020.113286_bb0205","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2020.113286_bb0210","doi-asserted-by":"crossref","first-page":"4070935","DOI":"10.1155\/2018\/4070935","article-title":"Effects of long-term treatment with a blend of highly purified olive Secoiridoids on cognition and brain ATP levels in aged NMRI mice","volume":"2018","author":"Reutzel","year":"2018","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.expneurol.2020.113286_bb0215","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.nbd.2014.05.012","article-title":"Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons","volume":"69","author":"Richter","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2020.113286_bb0220","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/jnc.13410","article-title":"Mitochondrial dysfunction in a transgenic mouse model expressing human amyloid precursor protein (APP) with the Arctic mutation","volume":"136","author":"Ronnback","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2020.113286_bb0225","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.bcp.2010.04.018","article-title":"Olesoxime prevents microtubule-targeting drug neurotoxicity: selective preservation of EB comets in differentiated neuronal cells","volume":"80","author":"Rovini","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.expneurol.2020.113286_bb0230","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/00005072-198911000-00009","article-title":"A4 protein in Alzheimer's disease: primary and secondary cellular events in extracellular amyloid deposition","volume":"48","author":"Rozemuller","year":"1989","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2020.113286_bb0235","first-page":"A227","article-title":"Alzheimer-disease - insolubility of paired helical filaments (Phf) and the potential role of enzymatic cross-linking","volume":"32","author":"Selkoe","year":"1982","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2020.113286_bb0240","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1749-6632.1996.tb34401.x","article-title":"The role of APP processing and trafficking pathways in the formation of amyloid beta-protein","volume":"777","author":"Selkoe","year":"1996","journal-title":"Ann.N.Y.Acad.Sci."},{"key":"10.1016\/j.expneurol.2020.113286_bb0245","doi-asserted-by":"crossref","first-page":"101214","DOI":"10.1016\/j.redox.2019.101214","article-title":"Cholesterol enrichment in liver mitochondria impairs oxidative phosphorylation and disrupts the assembly of respiratory supercomplexes","volume":"24","author":"Solsona-Vilarrasa","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.expneurol.2020.113286_bb0250","doi-asserted-by":"crossref","first-page":"S455","DOI":"10.3233\/JAD-179915","article-title":"Mitochondrial function, dynamics, and permeability transition: a complex love triangle as a possible target for the treatment of brain aging and Alzheimer's disease","volume":"64","author":"Stockburger","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.expneurol.2020.113286_bb0255","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1016\/j.neuropharm.2012.02.013","article-title":"Olesoxime delays muscle denervation, astrogliosis, microglial activation and motoneuron death in an ALS mouse model","volume":"62","author":"Sunyach","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2020.113286_bb0260","article-title":"Mitochondria and mitochondrial cascades in Alzheimer's disease","author":"Swerdlow","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.expneurol.2020.113286_bb0265","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mehy.2003.12.045","article-title":"A \u201cmitochondrial cascade hypothesis\u201d for sporadic Alzheimer's disease","volume":"63","author":"Swerdlow","year":"2004","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.expneurol.2020.113286_bb0270","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.expneurol.2009.01.011","article-title":"The Alzheimer's disease mitochondrial cascade hypothesis: an update","volume":"218","author":"Swerdlow","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2020.113286_bb0275","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.bbadis.2013.09.010","article-title":"The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives","volume":"1842","author":"Swerdlow","year":"2014","journal-title":"BBA - Mol. Basis Dis."},{"key":"10.1016\/j.expneurol.2020.113286_bb0280","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3233\/JAD-132690","article-title":"Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis","volume":"41","author":"Tan","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.expneurol.2020.113286_bb0285","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bcp.2019.07.002","article-title":"Olesoxime in neurodegenerative diseases: scrutinising a promising drug candidate","volume":"168","author":"Weber","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.expneurol.2020.113286_bb0290","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.pain.2009.09.006","article-title":"Olesoxime (cholest-4-en-3-one, oxime): analgesic and neuroprotective effects in a rat model of painful peripheral neuropathy produced by the chemotherapeutic agent, paclitaxel","volume":"147","author":"Xiao","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.expneurol.2020.113286_bb0295","doi-asserted-by":"crossref","first-page":"11731","DOI":"10.1074\/jbc.M412898200","article-title":"Altered cholesterol metabolism in Niemann-pick type C1 mouse brains affects mitochondrial function","volume":"280","author":"Yu","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2020.113286_bb0300","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.clinthera.2013.11.006","article-title":"Molecular therapeutic strategies for spinal muscular atrophies: current and future clinical trials","volume":"36","author":"Zanetta","year":"2014","journal-title":"Clin. Ther."},{"key":"10.1016\/j.expneurol.2020.113286_bb0305","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3233\/JAD-141890","article-title":"Characterization of ATP alternations in an Alzheimer's disease transgenic mouse model","volume":"44","author":"Zhang","year":"2015","journal-title":"J. Alzheimers Dis."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488620301175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488620301175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:56:36Z","timestamp":1758002196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488620301175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":61,"alternative-id":["S0014488620301175"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2020.113286","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Olesoxime improves cerebral mitochondrial dysfunction and enhances A\u03b2 levels in preclinical models of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2020.113286","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113286"}}